Trials / Completed
CompletedNCT03518645
Optimal Lesion Preparation With Non-compliant Balloons Before Implantation Of Bioresorbable Scaffolds
Optimal Lesion Preparation With Non-compliant Balloons for the Implantation of Bioresorbable Vascular Scaffolds (BVS) -OPRENBIS Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 43 (actual)
- Sponsor
- KCRI · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Study aim : To compare a novel strategy of lesion preparation with noncompliant balloons before implantation of BVS. Hypothesis: Predilatation with non-compliant balloons could facilitate optimal deployment of BVS. By achieving good scaffold apposition a need for post-dilatation could be significantly reduced. This is expected to result in better short- and long-term outcomes.
Detailed description
Study design: Following pre-dilatation a BVS will be implanted and optical coherence tomography (OCT) will be performed in all patients. After OCT post-dilatation with non-compliant balloons might be performed if this is considered necessary by the treating interventionist. Final OCT will be performed in all patients. 1:1 Randomization of two strategies before the implantation of bioresorbable scaffolds: * OPN strategy (study group): pre-dilatation with OPN® NC (non-compliant) Super High Pressure PTCA (percutaneous transluminal coronary angioplasty) balloons * standard strategy (control group): pre-dilatation with a standard (compliant) balloon Enrolment: Randomization of 50 patients * 25 in the OPN strategy (study group) * 25 in the standard strategy (control group)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | OPN strategy | Predilatation with OPN balloon will be performed as a lesion preparation for BVS Absorb implantation. |
| DEVICE | standard strategy | Predilatation with standard balloon will be performed as a lesion preparation for BVS Absorb implantation. |
Timeline
- Start date
- 2015-03-01
- Primary completion
- 2016-12-01
- Completion
- 2018-03-29
- First posted
- 2018-05-08
- Last updated
- 2018-05-08
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT03518645. Inclusion in this directory is not an endorsement.